Communiqués SkinBioTherapeutics plc

Actions

SBTX

GB00BF33H870

Temps Différé London S.E. Autres places de cotation 08:59:59 02/07/2024			Varia. 5j.	Varia. 1 janv.
9 ^GBX	0,00 %		-7,69 %	-40,98 %

18/06	BÉNÉFICES ET TRANSACTIONS : Cordel se réjouit de l'obtention d'un contrat au Moyen-Orient	AN
05/04	SkinBioTherapeutics reçoit un avis de conversion d'obligations de la part de Macquarie	MT

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

SkinBioTherapeutics will "continue to be flexible enough to adapt to opportunities"	19/12/22	AQ
SkinBioTherapeutics will 'continue to be flexible enough to adapt to opportunities'	19/12/22	EQ
SkinBioTherapeutics : Positive data for AxisBiotix-Ps™ food supplement consumer study unveiled	26/05/21	PU
SkinBioTherapeutics : Initiation of oral health development programme \| 27 April 2021» Click here to view website page / read more	27/04/21	PU
SkinBioTherapeutics : New oral health research programme initiated with the University of Manchester	27/04/21	PU
SkinBioTherapeutics : New research agreement initiated with the University of Manchester	27/04/21	PU
SkinBioTherapeutics : Research programme with University of Manchester \| 08 April 2021» Click here to view website page / read more	08/04/21	PU
SkinBioTherapeutics : Half Year Results	03/03/20	PU
SkinBioTherapeutics : signs agreement with Winclove Probiotics to develop psoriasis food supplement	19/02/20	PU
SkinBioTherapeutics : announces a Commercial & Manufacturing Agreement with Speciality Chemical Company, Croda Plc	20/11/19	PU
Skinbiotherapeutics : Second Price Monitoring Extn	28/08/19	PU
Skinbiotherapeutics : Price Monitoring Extension	28/08/19	PU
Skinbiotherapeutics : Business Update and Board Changes	04/07/19	PU
Skinbiotherapeutics : Our skin is crawling with bacteria - and that's good news	25/06/19	PU
Skinbiotherapeutics : Director Appointment	18/04/19	PU
Skinbiotherapeutics : Director Dealing	16/04/19	PU
Skinbiotherapeutics : SkinBiotix® shows efficacy in first human study	08/04/19	PU
Skinbiotherapeutics : SkinBiotix shows efficacy in first human study	08/04/19	PU
Skinbiotherapeutics : CEO Designate Appointment	29/03/19	PU
Skinbiotherapeutics : Commencement of final phase of human studies	20/11/18	PU

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués SkinBioTherapeutics plc

Actions

SBTX

GB00BF33H870

Communiqués

Filtres